Adial Pharmaceuticals Inc (ADIL)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Adial Pharmaceuticals Max Drawdown (5Y): 99.30% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.30% |
| September 30, 2024 | 99.30% |
| August 31, 2024 | 99.30% |
| July 31, 2024 | 99.30% |
| June 30, 2024 | 99.30% |
| May 31, 2024 | 99.30% |
| April 30, 2024 | 99.30% |
| March 31, 2024 | 99.30% |
| February 29, 2024 | 99.30% |
| January 31, 2024 | 99.07% |
| December 31, 2023 | 99.07% |
| November 30, 2023 | 99.07% |
| October 31, 2023 | 99.07% |
| September 30, 2023 | 98.79% |
| August 31, 2023 | 98.43% |
| July 31, 2023 | 97.57% |
| June 30, 2023 | 97.56% |
| May 31, 2023 | 97.56% |
| April 30, 2023 | 97.56% |
| March 31, 2023 | 97.56% |
| February 28, 2023 | 97.56% |
| January 31, 2023 | 97.56% |
| December 31, 2022 | 97.56% |
| November 30, 2022 | 96.89% |
| October 31, 2022 | 96.63% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.80% |
| August 31, 2022 | 93.56% |
| July 31, 2022 | 92.61% |
| June 30, 2022 | 87.40% |
| May 31, 2022 | 87.40% |
| April 30, 2022 | 87.40% |
| March 31, 2022 | 87.40% |
| February 28, 2022 | 87.40% |
| January 31, 2022 | 87.40% |
| December 31, 2021 | 87.40% |
| November 30, 2021 | 87.40% |
| October 31, 2021 | 87.40% |
| September 30, 2021 | 87.40% |
| August 31, 2021 | 87.40% |
| July 31, 2021 | 87.40% |
| June 30, 2021 | 87.40% |
| May 31, 2021 | 87.40% |
| April 30, 2021 | 87.40% |
| March 31, 2021 | 87.40% |
| February 28, 2021 | 87.40% |
| January 31, 2021 | 87.40% |
| December 31, 2020 | 87.40% |
| November 30, 2020 | 87.40% |
| October 31, 2020 | 87.40% |
| September 30, 2020 | 87.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.95%
Minimum
Nov 2019
99.30%
Maximum
Feb 2024
92.06%
Average
87.40%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -70.95 |
| Beta (5Y) | 1.294 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.31% |
| Historical Sharpe Ratio (5Y) | -0.5691 |
| Historical Sortino (5Y) | -1.257 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.91% |